The Indian Pharmacopoeia Commission (IPC) held a national conference, 'Ensuring Quality of Blood and Blood Components through IP 2026', at its Ghaziabad campus on 24 June 2026.
Indian Pharmacopoeia 2026 carries 20 monographs on blood and blood components — standards found in no other pharmacopoeia in the world.
IP 2026 is the 10th edition, released on 2 January 2026 in New Delhi by Union Health Minister J. P. Nadda.
More than 160 participants from six states attended, including blood centre professionals and State Licensing Authorities.
Harsh Mangla, Joint Secretary in the Union health ministry, addressed the conference virtually.
A monograph is the official written standard for one drug or product: its identity, purity, strength and the tests it must pass. Once in the Indian Pharmacopoeia it is legally enforceable, so a blood unit that fails the monograph is not of standard quality.
Simple Analogy: A BIS specification sheet, but for a medicine.
Makes the standards in the current edition of the Indian Pharmacopoeia the legal standard of quality for drugs made or sold in India. Blood and its components are regulated as drugs under the Act.
Revised the rules for blood centres and blood components; the 20 monographs in IP 2026 are aligned with these rules.
Autonomous institution that publishes the Indian Pharmacopoeia and the National Formulary of India and supplies reference substances; operational as an autonomous body since 1 January 2009
State drug regulators that license and inspect blood centres under the Drugs and Cosmetics Act and enforce the new monographs
1st edition
2nd edition
3rd edition
4th edition
5th edition
6th edition
7th edition
8th edition
9th edition
10th edition (IP 2026) released; first to carry blood component monographs
GS Paper II > Health; Prelims > Statutory and regulatory bodies in health
General Awareness > Organisations and headquarters
Consider the following statements: 1. Other than those made by humans, nanoparticles do not exist in nature. 2. Nanoparticles of some metallic oxides are used in the manufacture of some cosmetics. 3. Nanoparticles of some commercial products which enter the environment are unsafe for humans. Which of the statements given above is/are correct?
Answer: 2 and 3
India's official book of drug standards, published by the IPC
The legally recognised specification for a single drug or product
Monitoring of adverse reactions linked to blood transfusion and donation